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Objective. To quantify the inﬂuence of type 2 diabetes risk distribution on prevention beneﬁt and apply a
method to optimally identify population targets.
Methods.We used data from the 2011 Canadian Community Health Survey (N=45,040) and the validated
Diabetes Population Risk Tool to calculate 10-year diabetes risk. We calculated the Gini coefﬁcient as a measure
of risk dispersion. Intervention beneﬁt was estimated using absolute risk reduction (ARR), number-needed-to-
treat (NNT), and number of cases prevented.
Results. There is a wide variation of diabetes risk in Canada (Gini=0.48) and with an inverse relation to
risk (r =−0.99). Risk dispersion is lower among individuals meeting an empirically derived risk cut-off
(Gini = 0.18). Targeting prevention based on a risk cut-off (10-year risk ≥ 16.5%) resulted in a greater
number of cases prevented (340 thousand), higher ARR (7.7%) and lower NNT (13) compared to targeting
individuals based on risk factor targets.
Conclusions. This study provides empirical evidence to demonstrate that risk variability is an important
consideration for estimating the prevention beneﬁt. Prioritizing target populations using an empirically
derived cut-off based on a multivariate risk score will result in greater beneﬁt and efﬁciency compared to
risk factor targets.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
A key component tomanage the burden of type 2 diabetes (T2DM) in
the population is accurately identifying and characterizing baseline risk of
developing T2DM in the population in order to appropriately plan and
target prevention strategies. This includes articulating both the level of
risk (likelihood of developing diabetes in the future) and the distribution
of risk (what proportion of the population fall into a given risk category).
The idea of risk dispersion was originally proposed by Rose, where he
argued that variability of risk in the population can inﬂuence intervention
effectiveness in terms of high-risk versus population-wide prevention
(Rose, 1992). However, Rose's work focused on the conceptualization ofCanadian Community Health
0 University Avenue, Toronto,
. Open access under CC BY-NC-ND licerisk conferred by a single risk factor (i.e. blood pressure). The use of
predictive algorithms is an efﬁcient approach to identifying risk cut-offs
for targeted interventions that allows for the inclusion of multiple risk
factors (McLaren et al., 2010). These approaches have recently been
developed and validated for use at the population level (Manuel et al.,
2012; Rosella et al., 2011).
While risk algorithms are increasingly being used in clinical and
recently in population settings, further research is needed on how
to best interpret and apply risk-cut-offs to inform intervention
approaches. For example, it is not clear what magnitude of diabetes
risk (e.g. 10-year risk ≥ 20%) would result in the greatest population
beneﬁt from a given diabetes prevention strategy. Most risk cut-offs
identiﬁed from other algorithms appear arbitrary and are not designed
to speciﬁcally maximize prevention outcomes. An important cut-off
attribute that is currently missing from prevention strategies is
maximizing strategy efﬁc\acy, meaning the risk level used to identify
target populations balances the number of individuals targeted with
the potential beneﬁt. In addition, few studies have directly examined
how dispersion and concentration of diabetes risk in the population
can inﬂuence the impact of a given strategy.nse.
18 L.C. Rosella et al. / Preventive Medicine 58 (2014) 17–21The objectives of this study are to demonstrate how the dispersion of
risk in the population, measured by the Gini coefﬁcient, is correlated
with the population risk of diabetes and to generate empiric risk
cut-offs based on a validated risk score in order to maximize the
population beneﬁt as measured by absolute risk reduction in the
population.
Methods
We ﬁrst updated an existing validated risk prediction algorithm for incident
diabetes, referred herein as DPoRT 2.0. DPoRT is a statistical model based on the
Weibull survival distribution and is validated to calculate up to 10-year diabetes
risk in any population-based data that contains self-reported risk factor
information on age, height and weight, ethnicity, education, immigrant status,
hypertension, self-reported heart disease, income, smoking and sex for those
age 20 years and older and who are currently without diabetes. The original
risk algorithm was based on a cohort of individuals 19,861 ≥ 20 years of age
without diabetes followed between 1996 and 2005 and validated in two
external cohorts in Ontario (N=26,465) andManitoba (N=9899). Full details
of development and validation can be found in a previous study (Rosella et al.,
2011).
DPoRT 2.0 follows the same methodology with updated coefﬁcients based
onmore recent data including individuals from the original 1996Ontario cohort
and the Ontario respondents of Cycle 1.1 (2001) and 2.1 (2003) of the Canadian
Community Health Survey (CCHS) linked to the Ontario Diabetes Database
(ODD) with follow-up until 2011 (Hux and Ivis, 2005) resulting in a total
sample size of 69,606 individuals and 667,337 person-years of follow-up.
DPORT 2.0 was externally validated in Ontario respondents to the 2005 CCHS
linked to the ODD with follow-up until 2011. We examined two indices of
model performance: discrimination and calibration. Model discrimination is
the ability to correctly classify those with and without the disease based on
predicted risk, i.e. correctly ranking those who will and will not develop
diabetes. Discrimination is measured using a C statistic, which is analogous to
the area under the receiver operating characteristic curve. This study uses a C
statistic modiﬁed for survival data developed by Pencina and D'Agostino
(2004). Calibration or accuracy is the extent of agreement between predicted
and observed outcomes. It is measured using the Hosmer and Lemeshow
statistic (H–L test), a χ2 test, which measures observed and predicted values
over deciles of predicted risk (D'Agostino et al., 2001; Hosmer and
Lemenshow, 2000). In our study, it was calculated by comparing observed
diabetes rates and DPoRT-predicted diabetes probabilities using a modiﬁed
version of the H–L χ2 statistic for time-to-event data (D'Agostino et al., 2001;
Nam, 2000). To mark sufﬁcient calibration, χ2 = 20 was used as a cut-off
(p b 0.01). The CCHS is a nationally representative household survey of
Canadians conducted by Statistics Canada which collects information on health
status, determinants of health, and health care utilization. Households are
selected though stratiﬁed, multilevel cluster sampling of private residences
using provinces and/or local planning regions as the primary sampling unit.
The surveys are conducted through telephone and in-person interviews and
all responses are self-reported. The target population consists of persons aged
12 and over residing in private dwellings in all provinces and territories, except
those living onAboriginal reserves, on Canadian Forces Bases, or in some remote
places. These surveys use a multistage stratiﬁed cluster design and provide
cross-sectional data representative of 98% of the Canadian population over the
age of 12 years. All surveys used for development, validation, and application
of DPoRT attained at least a 75% overall response rate (Statistics Canada, 2002,
2003).
We applied the validated DPoRT 2.0 to Canadian adults (age≥20), who are
non-pregnant, free of diabetes and had valid information on risk factors in the
2011 CCHS Share ﬁle (N = 45,040). For every individual in the CCHS, we
calculated 10-year diabetes risk and summarized this risk at the national level.
We calculated conﬁdence intervals taking into account both coefﬁcient and
complex survey variation generated using bootstrap techniques (Kovacevic
et al., 2008).
The Gini coefﬁcient applied to DPoRT-estimated risk was used as a measure
of risk dispersion. The Gini coefﬁcient is a measure of statistical dispersion (also
known as variability) and can be simply deﬁned as the average of all the
absolute differences of pairs in a sample (Glasser, 1962). While typically used
to describe income inequality, it is a general statistic of inequality that has
been applied to a variety of other outcomes including other health indices
(Asada, 2005). A Gini coefﬁcient of zero expresses perfect equality where allvalues are the same for all individuals in a population (e.g. where everyone
has exactly the same diabetes risk). A Gini coefﬁcient of one expressesmaximal
inequality among values (e.g. where only one person has all the diabetes risk).
We examine the relationship between level of risk in the population and
dispersion of diabetes risk by ranking percentiles of the population and then
calculating the Gini coefﬁcient of the population included within percentile
groups (e.g. 0.1 represents the top 10% of the population ordered by risk
of diabetes). We plotted the relationship where the x axis represents
sections taken from the population ranked from the highest diabetes risk
to the lowest risk. As a greater proportion of the population is included,
the average risk in that section of the population decreases given that
lower risk groups are included. The y-axis represents the Gini coefﬁcient
for that section of the population. We then calculated the correlation
coefﬁcient of this relationship.
We examined how risk distribution measures would affect population
intervention strategies by calculating the beneﬁts of a hypothetical targeted
intervention strategy using different approaches for identifying the target
group that will receive the intervention. Speciﬁcally we quantiﬁed the impact
of an intervention targeting the general population and high-risk groups
based on single or dual risk factors (obesity and overweight among non-white
ethnicities) or based on an empirically-derived risk cut-off estimated from
DPoRT 2.0. We deﬁned population beneﬁt as the absolute risk reduction
(ARR) in 10-year diabetes risk (absolute difference in diabetes risk before and
after the intervention) and the corresponding number of diabetes cases
prevented. The number of diabetes cases prevented was determined by
summating the ARRmultiplied by the surveyweight for all targeted individuals.
The Number Needed to Treat (NNT) is equal to one over the mean value of the
ARR in the population. We based the effect of the diabetes prevention strategy
on a plausible range seen frommeta-analyses of intervention studies involving
an intensive lifestyle intervention, typically a combination of diet and physical
activity, which would have a larger effect on reducing 10-year diabetes risk
(Gillies et al., 2008). For the intervention strategy we used a 10-year risk
reduction of 30%; although, we examined a range of effect sizes (10–60%). We
derived an optimal cut-point to identify a diabetes risk score thatwould identify
individuals or groups that would beneﬁt from intervention. The empirically-
derived risk cut-off was based on a nonparametric discontinuity regression
function that maximizes the difference in mean ARR between those who meet
and do not meet the cut-point (Klotsche et al., 2009). This value is represented
as solid black line in Fig. 2.
Results
The updated algorithm (DPoRT 2.0) demonstrates excellent
accuracy (H–L χ2 b 20, p b 0.01?) and similar discrimination to the
original DPoRT (C-statistic = 0.77) (Fig. 1) (Appendix A). Overall,
based on the 2011 population, diabetes risk is 10% (9.6%, 10.4%)
translating to over 2.25million new diabetes cases expected in Canada
between 2011 and 2020. The 10-year baseline risk for diabetes in the
overall population and by important subgroups is reported in Table 1.
Ten-year diabetes risk varies by age, Body Mass Index (BMI), sex,
ethnicity, and quartile of risk. The absolute numbers of expected new
cases reﬂect variation in risk across the population, in addition to
distribution of sub-groups within the Canadian population.
Risk is variable in the Canadian population (Gini=0.48); however,
within subgroups there is a range of risk dispersions from as low as
0.11 to as high as 0.52 (Table 1). Diabetes risk is less variable within
older ages, among those that are obese, and within quartiles of risk.
High variability in 10-year diabetes risk is noted within certain ethnic
groups and among those under 45.
The degree of variability in diabetes risk is related to the magnitude
of diabetes risk such that the higher the diabetes risk score, the lower
the dispersion among the population that falls below that risk cut-off
(r=−0.99, Fig. 2). The empirically derived cut-off was determined to
be a risk of 16.5% (Fig. 3). Table 2 demonstrates the beneﬁt in targeting
individual or dual risk factors compared to targeting based on an
empirically derived risk cut-off. Risk dispersion is lower when using
the empirically derived risk cut-off based on DPoRT compared to a
single factor target, although they represent similar proportions of the
population (20% vs. 17%). Furthermore, targeting the population that
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Fig. 1. Predicted versus observed diabetes risk in the 2005–2011 Ontario CCHS (validation
cohort) demonstrating the accuracy of DPoRT 2.0 across the range of diabetes risk. The x
axis refers to quantile (15) of predicted risk. The y axis refers to the observed (bars) and
DPoRT predicted (dotted line) probability of developing diabetes in a 6-year period.
CCHS, Canadian Community Health Survey; DPoRT, Diabetes Population Risk Tool; NPHS.
Table 1
Baseline diabetes risk of the Canadian population overall and by important sub-groups.
10-Year diabetes
risk (%)
Number of
new cases
(1000s)
Diabetes risk
dispersion
index
19L.C. Rosella et al. / Preventive Medicine 58 (2014) 17–21falls above the empirically derived cut-off would result inmore diabetes
cases prevented and a greater ARR assuming the same intervention
effect (Table 2). Targeting based on an empirically derived risk cut-off
would result in the lowest NNT of 13, which represents the number of
people that would need to receive the intervention to prevent one
diabetes case (Table 2).Percent of
population
Estimate Estimate Gini
coefﬁcient
Overall 100 10 (9.6, 10.4) 2250 0.48
By sex
Females 52 8.9 (8.4, 9.4) 1028 0.48
Males 49 11.2 (10.6, 11.8) 1221 0.48
By age
b45 47 4.7 (4.3, 5.1) 494 0.48
45–60 30 13.8 (13.1, 14.5) 921 0.39
≥60 23 16 (15.3, 16.7) 835 0.32
By BMI (kg/m2)
b25 47 4.6 (4.2, 5.0) 490 0.46
25–30 34 11.3 (10.6, 11.9) 849 0.36
30–35 13 20 (18.6, 21.4) 559 0.29
≥35 5 26.8 (24.0, 29.6) 269 0.27
By ethnicitya
White 80 9.6 (9.2, 10) 1722 0.48
South Asian 3 11.3 (9.5, 13.2) 86 0.49
Off-reserve First
Nations
3 15.7 (13.9, 17.4) 110 0.48
Asian 6 9.7 (8.5, 11.0) 124 0.50
Black 2 12.7 (10.8, 14.6) 56 0.43
Otherb 6 11.9 (10.3, 13.6) 153 0.52
By quartile of risk
Q1 25 1.7 (1.5, 2.0) 97 0.21
Q2 25 4.6 (4.2, 5.0) 259 0.16
Q3 25 10.3 (9.8, 10.8) 577 0.11
Q4 25 23.4 (22.5, 24.4) 1317 0.20
a Ethnicity was ascertained by the question ‘To which ethnic or cultural groups do your
ancestors belong?’
b Other includes those who did not self-identify with the following Statistics Canada
(2001) deﬁnitions of ethnic groups: White, South Asian, Chinese, Black, Filipino,
Japanese, Korean, Aboriginal/First Nation (North American Indian, Métis or Inuit), or
those that self-identiﬁed with multiple ethnicities (i.e. mixed race).Discussion
This study quantiﬁed how risk dispersion (variability in diabetes
risk) is related to the magnitude of risk using a statistical measure of
dispersion and a validated risk tool. Other studies have used risk
algorithms to understand, compare and contrast different prevention
strategies for diabetes (Chamnan et al., 2012; Harding et al., 2006;
Manuel et al., 2012). This is the ﬁrst that statistically characterizes
diabetes risk dispersion using a validated population risk algorithm
in order to quantify its impact on beneﬁt and empirically derives
an optimal cut-point to target populations based on maximizing
differences in the absolute risk reduction between those who meet
and do not meet the cut-point.
It can be expected that the higher the dispersion, the more
challenging it is to realize a given effect of a targeted intervention
since baseline risk is a key driver. However, we found that even
among similar risk groups, deﬁned by established risk factors, risk
variation can ﬂuctuate signiﬁcantly depending on how that group is
deﬁned, pointing to the need for more global assessments of risk that
consider multiple dimensions of risk. Typically, baseline risk is used to
identify optimal target groups for intervention, but the variability in
risk is not considered. We show that in addition to baseline risk, risk
dispersion is also an important consideration that can inﬂuence the
beneﬁt revised from a prevention intervention.
We found that prioritizing target populations using an empirically
derived cut-off would result in greater population beneﬁt compared
to single risk factor targets, even when a similar proportion of thepopulation would be targeted. The empirical risk cut-point we derived
corresponds to a ‘moderate risk’ category according to existing
individual risk calculators (Canadian Task Force on Preventive Health
Care, 2012); however, these risk classiﬁcations were not statistically
derived based on maximizing treatment beneﬁt. This underscores the
importance of improving who we target and using tools to ensure our
prevention strategies are appropriate for both the level and dispersion
of risk in the population. Increasingly, the use of multivariate
risk algorithms are being encouraged to improve identiﬁcation of
individuals at risk by examining multiple dimensions of risk, but also
to provide a more efﬁcient way of a staged or multi-step screening
approach at the individual level (Buijsse et al., 2011; Canadian Task
Force on PreventiveHealth Care, 2012; Tabak et al., 2012). A particularly
novel contribution of this study is that it provides a mechanism by
which these principles can be applied to the population level, beyond
individual risk screening tools that have been recommended to guide
clinical prevention strategies (Buijsse et al., 2011). These algorithms
are difﬁcult to apply at the population level because of their reliance
on detailed clinical measures; data that rarely exist at the population
level. In addition, these models were designed to be used for individual
clinical decision-making and not for population risk assessment. To
date, a population risk algorithm that can be applied to existing self-
reported data has not yet been validated or used for individual risk
assessment. A recent systematic review of all diabetes risk scores and
models published in 2011 found that of over 90 existing diabetes risk
tools, DPoRT was the only tool built to inform population intervention
strategies for diabetes (Noble et al., 2011). Decision-makers often have
access to data on existing trends in diabetes (such as current diabetes
prevalence rates) and risk factors (such as obesity), but rarely are they
able to integrate these pieces of information together to inform
prevention strategies. However, for the same reasons that multivariate
0.1 0.2 0.3 0.4 0.5
0.
10
0.
15
0.
20
0.
25
0.
30
Proportion of the population targeted ordered by diabetes risk
G
in
i C
oe
ffi
ci
en
t
Fig. 2. The relationship between level of risk in the population and dispersion of diabetes risk measured using the Gini coefﬁcient. The x axis represents percentiles taken from the
population ranked from highest diabetes risk to lowest. The y axis represents the Gini coefﬁcient for that section n of the population.
20 L.C. Rosella et al. / Preventive Medicine 58 (2014) 17–21risk algorithms are increasingly being encouraged in clinical medicine,
this assessment is critical to determining the best approach to inform
policies and interventions that will reduce risk in the population and
arguably even more important given the associated complexities,
costs and challenges with population risk prevention (Burke et al.,
2003).
There are some limitations to notewhen interpreting these ﬁndings.
Firstly, we focused on a simpliﬁed intervention scenario that has a
ﬁxed effect across targeted interventions groups. It's possible that the
intervention impact could vary based on the population targeted.
This is an assumption that could be easily tested with good empirical
evidence to support the variation in effect, although studies have
shown that relative risk reductions are relatively constant across
populations with different baseline risk (Furukawa et al., 2002).
Although out of scope of this study, the composition of prevention
strategies, including the role of policies that facilitate prevention0.1
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Fig. 3. Absolute Risk Reductions (ARR) and Gini coefﬁcients in diabetes risk following a diabet
population based on DPoRT 2.0 risk. ARR values are plotted on the y-axis, the proportion of t
coefﬁcient for each targeted group is on the top x-axis. The black vertical line represents the em
that maximizes the difference in mean ARR between those who meet and do not meet the cut(Glickman et al., 2012; Ratner, 2012), is an important area of future
research that can be informed by population risk tools. Secondly,
DPoRT is validated to estimate risk of physician diagnosed diabetes,
and underestimates total diabetes risk (i.e. undiagnosed diabetes).
Finally, measurement error is always a possibility with the self-
reported risk factors used in this study. Although we have found
DPoRT estimates to be minimally inﬂuenced by measurement error
(Rosella et al., 2012), there is a possibility of misclassiﬁcation of risk.
This study provides a practical and meaningful way to better
understand how magnitude and distribution of diabetes risk in the
Canadian population can inﬂuence the beneﬁt of prevention strategies.
As risk is increasingly dispersed among the target population, thenature
of interventions and/or their expected impact must be modiﬁed.
Finally and importantly, this research demonstrates a mechanism
whereby routinely-collected population-level data can be used to
inform prevention approaches.0.3 0.5
n targeted ordered by diabetes risk
es intervention strategy that reduces 10-year risk by 30% targeted different groups of the
he population targeted and accordingly diabetes risk are plotted on the x-axis, and Gini
pirically derived cut-off derived from the nonparametric discontinuity regression function
-point (Klotsche et al., 2009).
Table 2
Description of target populations, risk dispersion, and outcomes of intervention strategies among these populations.
Target population Proportion
of
population
10-Year
diabetes risk (%)
Diabetes risk
dispersiona
Absolute risk reduction (ARR)
following targeted intervention
strategy (%)b
Number Needed to Treat to
prevent one case of diabetes
following targeted intervention
strategybc
Reduction in future diabetes
cases following targeted
intervention strategy
(thousands)b
All of Canada 100% 10.0 (9.6–10.4) 0.48 N/A N/A N/A
Obese individuals (BMI≥ 30kg/m2) 17% 21.8 (20.5–23.1) 0.30 6.5 15.3 248
Overweight (BMI≥ 25 kg/m2) and
non-white ethnicity
9% 19.1 (17.1–21.1) 0.38 5.7 17.5 109
Empirically derived cut-offa 20% 25.7 (24.6–26.9) 0.18 7.7 13.0 340
a Estimated using Gini coefﬁcient.
b Based on diabetes risk reduction of 30% (11).
c The Number Needed to Treat (NNT) is equal to one over the mean value of the absolute risk reduction (ARR) in the population.
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Appendix A. Calculating diabetes risk using DPoRT 2.0
Males:
μ = 10.3062 − 0.3629 × hypertension− 0.3483 × heart disease−
0.5697 × non-white ethnicity− 0.0585 × smoker + 0.1884 × attended
post-secondary + 0.1173 × top income quintile − 0 × (BMI b 23 &
age b 45) − 0.5520 × (23 ≤ BMI b 25 & age b 45) −
0.9521 × (25 ≤ BMI b 30 & age b 45) − 1.7162 × (30 ≤ BMI b 35 &
age b 45)− 2.3310 × (35 ≤ BMI & age b 45)− 1.3602 × (BMI b 23 &
age ≥ 45) − 1.6537 × (23 ≤ BMI b 25 & age ≥ 45) −
2.0563 × 25 ≤ (BMI b 30 & age ≥ 45) − 2.5513 × (30 ≤ BMI b 35 &
age≥45)−2.9353×(35≤BMI & age≥45).
Scale=0.7994
Females:
μ = 10.5777 − 0.4098 × hypertension − 0.4528 × non-white
ethnicity− 0.1477 × immigrant + 0.1939 × attended post-secondary−
0 × (BMI b 23 & age b 45)− 0.7432 × (23 ≤ BMI b 25 & age b 45)−
1.1521 × (25 ≤ BMI b 30 & age b 45) − 1.8479 × (30 ≤ BMI b 35 &
age b 45)− 2.0562× (35≤ BMI & age b 45)− 1.5832× (BMI=missing
& age b 45) − 0.7100 × (BMI b 23 & 45 ≤ age b 65) −
1.2338 × (23≤ BMI b 25 & 45≤ age b 65)− 1.8357 × (25≤ BMI b 30 &
45 ≤ age b 65) − 2.3742 × (30 ≤ BMI b 35 & 45 ≤ age b 65) −
2.6631 × (35 ≤ BMI & 45 ≤ age b 65) − 2.1988 × (BMI = missing &
45 ≤ age b 65) − 1.5956 × (BMI b 23 & age ≥ 65) −
1.6144 × (23 ≤ BMI b 25 & age ≥ 65) − 1.9830 × (25 ≤ BMI b 30 &
age ≥ 65) − 2.2148 × (30 ≤ BMI b 35 & age ≥ 65) −
2.6448×(35≤BMI & age≥65)−2.4209×(BMI=missing & age≥65).
Scale=0.8419
Note: All independent variables are centered on the mean value for
each province.
Note: Women with missing BMI have an elevated risk of diabetes.
They are included in the model.
For both males and females:
m ¼ log follow‐uptimeindaysð Þ–μ
scale
p ¼ 1− exp − expm 
Numberof diabetescases ¼ p  surveyweight:
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